Chapter 2 - THE CLINIC AFTER MIDNIGHT
Celeste drove forty minutes north.
Hale’s team followed at distance, using two vehicles and no lights.
Vincent watched the route on a secure tablet from his office.
Emma stayed upstairs with Lucy.
He had asked her to.
Not ordered.
That distinction mattered now.
At 11:18 p.m., Celeste’s car turned into a private rehabilitation clinic closed for the night.
MERCER PEDIATRIC NEUROREHABILITATION.
Of course.
Vincent stared at the map.
Hale’s voice came through the secure line.
“They entered through staff access.”
“Any other vehicles?”
“One black SUV. Registered to a medical supply company.”
“Which one?”
“Moretti Therapeutics Holdings.”
Vincent went still.
He knew the company.
Celeste chaired it.
It supplied rehabilitation equipment to private hospitals.
He had invested seed capital five years ago and never looked at operations.
A family favor.
His family had always been good at turning favors into structures.
“Who owns the clinic?”
“Mercer owns sixty percent. Moretti Therapeutics owns forty.”
Vincent swore softly.
He had financed the place indirectly.
His daughter’s doctor was business partners with his sister.
No one told him.
That was not an oversight.
Hale continued.
“We have exterior audio only. No warrant. No entry.”
“Good.”
Hale almost sounded surprised.
Vincent understood.
The old Vincent would have sent men inside.
Broken doors.
Taken files.
Threatened answers into existence.
The new one had learned something in one evening.
Evidence survives better than intimidation.
“Photograph everyone who enters.”
“Already doing it.”
At 11:46, another man arrived.
Dr. Harold Mercer’s research director.
Then a woman from the state medical billing board.
Then Celeste’s personal attorney.
This was not a romantic affair.
Not a spontaneous panic.
A meeting.
Prepared.
Vincent called Dr. Priya Shah.
She arrived at the estate just after midnight.
Forty-seven, calm, practical, no visible interest in Vincent’s reputation.
Good.
She reviewed Lucy’s records in the library.
Not the family office.
Vincent wanted neutral ground.
Emma sat at the far end holding a notebook.
Shah looked at her.
“You observed therapy?”
“Yes.”
“Tell me what you saw. No conclusions. Just behavior.”
Emma nodded.
Lucy became drowsier after certain appointments.
She cried when the left thigh was touched.
She could move the leg during play but seemed weaker during formal sessions.
Mercer’s assistants sometimes held her trunk firmly.
After injections, Lucy slept for hours.
Shah’s pen stopped.
“Injections?”
Vincent’s head snapped around.
Emma looked confused.
“Yes.”
“What injections?”
“I don’t know. Mercer said they reduced spasticity.”
Shah turned to Vincent.
“Were these documented?”
He handed her the pharmacy records.
She read.
Her expression changed.
“Botulinum toxin can be appropriate for pediatric spasticity. But dosing matters. Site selection matters. Timing matters. This amount is concerning if the chart is accurate.”
Vincent asked, “Could it make her weaker?”
“Yes.”
“Could it make her stop walking?”
Shah was careful.
“It could worsen functional weakness if overused or injected into muscles she still needed for compensation. I am not saying that happened. I am saying it requires immediate independent examination.”
Vincent nodded.
“Do it.”
“Now?”
“Yes.”
Shah looked at him.
“Your daughter is sleeping.”
Vincent felt shame again.
He was so desperate for answers he had almost repeated Mercer’s mistake.
Forcing the child because adults were afraid.
“Tomorrow morning.”
Shah nodded.
“Good.”
Emma looked at him.
Just for a second.
He knew she noticed the correction.
The next morning Lucy woke cheerful.
No therapy scheduled.
No Mercer.
Emma brought breakfast.
Vincent joined them.
That alone confused Lucy.
“Daddy no work?”
“Daddy is working here today.”
She accepted that.
Dr. Shah entered wearing no white coat.
She sat on the carpet.
Did not touch Lucy for five minutes.
They played with blocks.
Then with a soft red ball.
Then Shah asked whether Lucy wanted to show her how the walker worked.
Lucy looked at Emma.
Emma said, “Only if you want.”
Lucy nodded.
She stood.
One step.
Pause.
Another.
Shah watched everything.
Muscle activation.
Foot placement.
Fear.
Compensation.
Then she asked Lucy to sit and move her feet like she was “kicking bubbles.”
Lucy kicked both.
Left weaker.
But active.
Shah looked at Vincent.
“Your daughter has functional movement that is inconsistent with the severity described in Mercer’s last three reports.”
His throat tightened.
“What does that mean?”
“It means I want imaging, EMG testing, and a medication review before I say more.”
Lucy clapped.
“Done?”
Shah smiled.
“For now.”
Lucy crawled toward Emma.
Not Vincent.
He noticed.
He did not resent it.
That was progress too.
By afternoon, Hale had obtained public corporate records.
Moretti Therapeutics had paid Mercer’s clinic millions in “research support.”
Celeste personally approved the transfers.
One study involved botulinum toxin protocols in pediatric neurological rehabilitation.
Lucy’s name did not appear as a formal research subject.
But her treatment pattern matched the experimental protocol.
Vincent read the study outline twice.
Higher-frequency injection cycles.
Aggressive muscle tone suppression.
Outcome goal: functional gait normalization.
Risk: transient weakness.
Emma saw his face.
“What?”
He handed the page to Shah.
She read.
Then said the word Vincent feared.
“Experimental.”
His vision narrowed.
“Was Lucy enrolled?”
“No consent form in these records.”
“Could Celeste consent?”
“Not unless she held legal guardianship or delegated medical authority.”
Vincent’s jaw tightened.
She did not.
He was sole legal guardian.
Lucy’s mother had died eighteen months earlier.
He had never delegated authority.
So how did the clinic obtain signatures?
Hale found the answer.
A durable medical authorization form.
Signed by Vincent Moretti.
Except Vincent had never seen it.
His signature looked convincing.
Too convincing.
He stared at the scanned page.
Forgery.
Then he noticed the witness signature.
Celeste Moretti.
His own sister had witnessed a forged document granting herself and Mercer control over Lucy’s treatment.
Why?
Money could explain some.
Research prestige.
Company valuation.
Mercer’s career.
But Celeste already had money.
More than she could spend.
So did Mercer.
There had to be more.
Hale called from the clinic surveillance.
“They’re leaving.”
“All of them?”
“Mercer and the lawyer left. Celeste stayed.”
“Why?”
“We don’t know.”
Then Hale sent a photo.
Celeste exiting the clinic through a rear door carrying a small red medical cooler.
Vincent’s stomach turned.
“Follow.”
They tracked her to a private storage facility attached to Moretti Therapeutics.
She went inside.
Came out without the cooler.
Vincent contacted federal health investigators through an attorney he trusted.
No threats.
No break-in.
A proper emergency preservation request went out.
By evening, a judge signed a narrow warrant based on suspected forged medical authorization and unreported controlled biologic use.
Agents entered the storage unit.
Inside were dozens of red coolers.
Medication vials.
Patient codes.
Research binders.
And one locked file cabinet labeled M-17.
Lucy Moretti’s birth date corresponded to 17.
The file contained treatment notes not present in her official chart.
One entry read:
Subject demonstrates greater residual function than anticipated. Family observation risk increasing.
Another:
Recommend continued suppression until transfer decision complete.
Vincent stopped reading.
“What transfer?”
Shah turned the page.
A legal form.
Proposed temporary guardianship transfer.
From Vincent Moretti.
To Celeste Moretti.
Basis:
Father medically and behaviorally unfit due to violent occupational exposure and inability to manage disabled child’s complex needs.
His blood went cold.
This was not only about research.
Celeste was building a case to take Lucy.
Hale found another document.
A draft valuation.
If Celeste became Lucy’s legal guardian, control of the trust left by Lucy’s mother would shift to her.
The trust held twelve percent of Moretti Holdings.
Enough to change board control.
There it was.
Money.
Power.
Lucy’s body had become corporate leverage.
Vincent wanted to destroy something.
Instead he walked upstairs.
Emma was reading to Lucy.
He stood in the doorway and listened until the page ended.
Then he said, “Emma.”
She looked up.
“Yes?”
“Can I speak with you?”
They stepped into the hall.
He handed her the forged authorization.
She read slowly.
Her face changed.
“What is this?”
“My sister tried to take medical control of Lucy.”
Emma looked toward the nursery.
“Why?”
“Because Lucy owns shares.”
Emma stared.
“She’s two.”
“I know.”
The disgust in her face made him feel worse.
“Mr. Moretti…”
“Vincent.”
She looked startled.
“Vincent.”
First time.
He almost felt it physically.
She continued.
“You need to keep Lucy away from Mercer.”
“I am.”
“And Celeste.”
“Yes.”
Emma nodded.
Then asked the question everyone else had avoided.
“What happened to Lucy’s mother?”
Vincent went still.
“My wife died.”
“How?”
“Car accident.”
“When?”
“Three weeks before Lucy’s neurological infection.”
Emma’s face changed.
Not because she knew something.
Because the timing was wrong.
One catastrophe.
Then another.
Three weeks apart.
Vincent had always treated them as separate tragedies.
Why wouldn’t he?
Now every coincidence felt diseased.
He went back to the old file.
His wife, Sofia Moretti.
Vehicle failure.
Single-car crash.
Brake system issue.
No foul play established.
Then Lucy became ill.
Viral encephalitis.
Hospitalized.
Recovered with weakness.
Celeste appeared constantly during both crises.
Helpful.
Organized.
Managing lawyers.
Managing doctors.
Managing everything.
Vincent called Hale.
“Pull Sofia’s crash file.”
“Boss?”
“Everything.”
A long pause.
“You think this goes back that far?”
May you like
Vincent looked through the nursery doorway at Lucy leaning against Emma, laughing at the book.
“I think I stopped asking questions too early.”
